Recombinant soluble CD226 protein directly inhibits cancer cell proliferation in vitro

International Immunopharmacology

Volumn 19, Issue 1, 2014, Pages 119-126

  Hou, Shengke ^a   Zheng, Xiaodong ^a   Wei, Haiming ^a,b   Tian, Zhigang ^a,b   Sun, Rui ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Cell proliferation; Soluble CD226; Tumor

Indexed keywords

ANTIMITOTIC AGENT; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; NECTIN 2; RECOMBINANT PROTEIN; RECOMBINANT SOLUBLE CD226 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL DIVISION; CELL LABELING; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STRAIN K 562; COCULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SOLID TUMOR;

CELL PROLIFERATION; SOLUBLE CD226; TUMOR;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CHO CELLS; CRICETULUS; HELA CELLS; HUMANS; K562 CELLS; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

EID: 84893618838     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.01.012     Document Type: Article

References (22)

1. G.F. Burns, T. Triglia, J.A. Werkmeister, C.G. Begley, and A.W. Boyd TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors J Exp Med 161 1985 1063 1078 (Pubitemid 15011325)
2. A. Shibuya, D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, and T. McClanahan et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes Immunity 4 6 Jun 1996 573 581 (Pubitemid 26233311)
3. J.L. Scott, S.M. Dunn, B. Jin, A.J. Hillam, S. Walton, and M.C. Berndt et al. Characterization of a novel membrane glycoprotein involved in platelet activation J Biol Chem 264 1989 13475 13482 (Pubitemid 19198425)
4. P.D. Sherrington, J.L. Scott, B. Jin, D. Simmons, D.J. Dorahy, and J. Lloyd et al. TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression J Biol Chem 272 1997 21735 21744 (Pubitemid 27382787)
5. M. Cheng, Y. Chen, W. Xiao, R. Sun, and Z. Tian NK cell-based immunotherapy for malignant diseases Cell Mol Immunol 10 2013 230 252
6. Yoshimi Takai, Wataru Ikeda, Hisakazu Ogita, and Yoshiyuki Rikitake The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin Annu Rev Cell Dev Biol 24 2008 309 342
7. Zhuwei Xu, and Boquan Jin A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions Cell Mol Immunol 7 2010 11 19
8. C.L. Mendelsohn, E. Wimmer, and V.R. Racaniello Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily Cell 56 5 Mar 10 1989 855 865 (Pubitemid 19082521)
9. S. Fabre, N. Reymond, F. Cocchi, L. Menotti, P. Dubreuil, and G. Campadelli-Fiume et al. Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin 4 bind to the predicted C-C′-C″-D beta-strands of the nectin1 V domain J Biol Chem 277 30 Jul 26 2002 27006 27013 (Pubitemid 34951712)
10. H. Ogita, and Y. Takai Activation of Rap1, Cdc42, and rac by nectin adhesion system Methods Enzymol 406 2006 415 424 (Pubitemid 43207455)
11. H. Nakanishi, and Y. Takai Roles of nectins in cell adhesion, migration and polarization Biol Chem 385 10 Oct 2004 885 892 (Pubitemid 39481135)
12. K. Irie, K. Shimizu, T. Sakisaka, W. Ikeda, and Y. Takai Roles and modes of action of nectins in cell-cell adhesion Semin Cell Dev Biol 15 6 Dec 2004 643 656 (Pubitemid 39550244)
13. Z. Xu, T. Zhang, R. Zhuang, Y. Zhang, W. Jia, and C. Song et al. Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients BMC Immunol 10 Jun 2 2009 34
14. C. Bottino, R. Castriconi, D. Pende, P. Rivera, M. Nanni, and B. Carnemolla et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule J Exp Med 198 4 Aug 18 2003 557 567 (Pubitemid 37040390)
15. T. Nheu, H. He, Y. Hirokawa, F. Walker, J. Wood, and H. Maruta PAK is essential for RAS-induced up regulation of cyclin D1 during the G1 to S transition Cell Cycle 3 1 Jan 2004 71 74 (Pubitemid 40268591)
16. D.M. Appledorn, K.H. Dao, S. O'Reilly, V.M. Maher, and J.J. McCormick Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts BMC Cancer 10 Jan 12 2010 13 10.1186/1471-2407-10-13
17. T. Kwon, D.Y. Kwon, J. Chun, J.H. Kim, and S.S. Kang Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1 J Biol Chem 275 1 Jan 7 2000 423 428 (Pubitemid 30039001)
18. F. Valderrama, S. Thevapala, and A.J. Ridley Radixin regulates cell migration and cell-cell adhesion through Rac1 J Cell Sci 125 Pt. 14 Jul 15 2012 3310 3319
19. F.P. Lai, M. Szczodrak, J.M. Oelkers, M. Ladwein, F. Acconcia, and S. Benesch et al. Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases Mol Biol Cell 20 14 Jul 2009 3209 3223
20. S. Koike, H. Horie, I. Ise, A. Okitsu, M. Yoshida, and N. Iizuka et al. The poliovirus receptor protein is produced both as membrane-bound and secreted forms EMBO J 9 10 Oct 1990 3217 3224
21. B. Baury, D. Masson, B.M. McDermott Jr., A. Jarry, H.M. Blottière, and P. Blanchardie et al. Identification of secreted CD155 isoforms Biochem Biophys Res Commun 309 1 Sep 12 2003 175 182 (Pubitemid 36999774)
22. Yang-Xin Fu New immune therapy targets tumor-associated environment: from bone marrow to tumor site Cell Mol Immunol 9 2012 1 2